HIGHFDA DEVICE

Medtronic Recalls Stent System Due to Migration Risk

Medtronic recalled its Abre Venous Self-Expanding Stent System on December 4, 2025, due to a potential Nitinol anomaly. This issue may lead to reduced stent diameter and corresponding radial force, increasing the risk of stent migration. The recall affects 442 units distributed worldwide, including the U.S.

Official notice
MedtronicHealth & Personal CareMedical DevicesUDI-DI (GTIN): 00763000547332 00763000547271 00763000547318 00763000547264 00643169796225 00643169796300 00643169796294 00643169796232 00643169796287 00763000547325 00643169796300 00763000547257 Serial/Lot numbers C112511 C113253 C113795 C117416 C117482 C121084 C123953 C133327 C133329 C134478 C138060 C150325

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
December 4, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
December 4, 2025
Hazard Level
HIGH
Brand
Medtronic
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Medtronic
Product type
Self-Expanding Stent
Model numbers
UDI-DI (GTIN): 00763000547332 00763000547271 00763000547318 00763000547264 00643169796225 00643169796300 00643169796294 00643169796232 00643169796287 00763000547325 00643169796300 00763000547257 Serial/Lot numbers C112511 C113253 C113795 C117416 C117482 C121084 C123953 C133327 C133329 C134478 C138060 C150325
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    December 4, 2025

  2. Reported by FDA DEVICE

    January 21, 2026

  3. RecallRadar source check

    January 28, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Stents may be impacted by a Nitinol anomaly which causes a reduced stent diameter when deployed and corresponding reduced radial force. Issue may result in stent migration.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic Inc or your healthcare provider for instructions. Notification method: Letter

About This Product

The Abre Venous Self-Expanding Stent System is a medical device used to treat venous obstructions. Patients typically receive this stent to improve blood flow in affected veins.

Why This Is Dangerous

The Nitinol anomaly can cause the stent to reduce in diameter when deployed, which compromises its effectiveness and can lead to migration from the intended location.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Patients using this stent face potential risks that may require medical intervention, making this recall critical for ensuring patient safety.

Practical Guidance

How to identify if yours is affected

  1. Check model numbers on the device packaging or documentation.
  2. Verify if the stent falls within the recalled model numbers listed above.
  3. Consult your healthcare provider for confirmation.

Where to find product info

Model numbers and lot numbers can typically be found on the device packaging or accompanying documentation.

What timeline to expect

Expect a response from the manufacturer within 4-6 weeks regarding the recall process and refunds.

If the manufacturer is unresponsive

  • Contact Medtronic directly for updates.
  • Document all communication attempts with the manufacturer.

How to prevent similar issues

  • Always check for current recalls on medical devices before use.
  • Consult with your healthcare provider about the most recent safety information.

Documentation advice

Keep all receipts, correspondence with the manufacturer, and any medical records related to the stent.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall involves the Abre Venous Self-Expanding Stent System with model numbers AB9G14120090, AB9G12100090, AB9G14080090, and others. The stents were distributed globally, including in the U.S. and several countries in Europe and Asia. The price range is not specified.

Key Facts

  • Recall date: December 4, 2025
  • Total units recalled: 442
  • Affected countries include the US, UK, and Australia
  • Immediate action required by users

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
UDI-DI (GTIN): 00763000547332 00763000547271 00763000547318 00763000547264 00643169796225 00643169796300 00643169796294 00643169796232 00643169796287 00763000547325 00643169796300 00763000547257 Serial/Lot numbers C112511 C113253 C113795 C117416 C117482 C121084 C123953 C133327 C133329 C134478 C138060 C150325
Affected States
ALL
Report Date
January 21, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more